CT, RECIST, and malignant pleural mesothelioma
- 1 July 2005
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 49, S37-S40
- https://doi.org/10.1016/j.lungcan.2005.03.030
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Modified RECIST criteria for assessment of response in malignant pleural mesotheliomaAnnals of Oncology, 2004
- Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesotheliomaLung Cancer, 2004
- Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2003
- Interobserver and Intraobserver Variability in Measurement of Non–Small-Cell Carcinoma Lung Lesions: Implications for Assessment of Tumor ResponseJournal of Clinical Oncology, 2003
- A multicentre phase II study of cisplatin and gemcitabine for malignant mesotheliomaBritish Journal of Cancer, 2002
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Cisplatin and Gemcitabine Treatment for Malignant Mesothelioma: A Phase II StudyJournal of Clinical Oncology, 1999
- Reporting results of cancer treatmentCancer, 1981